Sustained clinical improvement of a patient with decompensated Hepatitis B virus-related cirrhosis after treatment with lamivudine monotherapy

Tohoku Journal of Experimental Medicine

Volumn 210, Issue 1, 2006, Pages 29-36

  Nagasaki, Futoshi ^a   Ueno, Yoshiyuki ^a   Yamamoto, Takeshi ^b   Nakagomi, Yu ^a   Kido, Osamu ^a   Kakazu, Eiji ^a   Matsuda, Yasunori ^a   Kogure, Takayuki ^a   Yamagiwa, Yoko ^a   Kikuchi, Kumiko ^b   Fukushima, Koji ^a   Kanno, Noriatsu ^a   Niitsuma, Hirofumi ^a   Shimosegawa, Tooru ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU ROSAI HOSPITAL   (Japan)

Author keywords

Chronic hepatitis; HBV; Lamivudine

Indexed keywords

DIURETIC AGENT; FRESH FROZEN PLASMA; HEPATITIS B SURFACE ANTIGEN; HEPATITIS E ANTIGEN; LAMIVUDINE; VIRUS DNA;

ABDOMINAL RADIOGRAPHY; ADULT; ARTICLE; BRANCHED DNA SIGNAL AMPLIFICATION ASSAY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA DETERMINATION; DOSE RESPONSE; ENDOSCOPY; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAUNDICE; LABORATORY TEST; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FAILURE; LONG TERM CARE; NONHUMAN; PLASMA TRANSFUSION; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; VIRUS GENE; VIRUS INHIBITION; VIRUS LOAD;

ANTI-HIV AGENTS; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; LIVER; LIVER CIRRHOSIS; MIDDLE AGED; TREATMENT OUTCOME; VIRAL LOAD;

EID: 33748597946     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.210.29     Document Type: Article

References (20)

1. Arauz-Ruiz, P., Norder, H., Robertson, B.H. & Magnius, L.O. (2002) Genotype h: A new amerindian genotype of hepatitis B virus revealed in central america. J. Gen. Virol., 83, 2059-2073.
2. Dienstag, J.L., Schiff, E.R., Mitchell, M., Casey, D.E., Jr., Gitlin, N., Lissoos, T., Gelb, L.D., Condreay, L., Crowther, L., Rubin, M. & Brown, N. (1999a) Extended lamivudine retreatment for chronic hepatitis B: Maintenance of viral suppression after discontinuation of therapy. Hepatology, 30, 1082-1087.
3. Dienstag, J.L., Schiff, E.R., Wright, T.L., Perrillo, R.R, Hann, H.W., Goodman, Z., Crowther, L., Condreay, L.D., Woessner, M., Rubin, M. & Brown, N.A. (1999b) Lamivudine as initial treatment for chronic hepatitis B in the united states. N. Engl. J. Med, 341, 1256-1263.
4. Inoue, J., Ueno, Y., Kanno, N., Anzai, H., Kondo, Y., Moritoki, Y., Mikami, E., Chiba, M., Kogure, T., Nagasaki, F., Fukushima, K., Iwasaki, T., Satomi, S. & Shimosegawa, T. (2005) Living related liver transplantation for acute fulminant hepatitis B: Experience from two possible hyper-acute cases. Tohoku J. Exp. Med., 205, 197-204.
5. Kapoor, D., Guptan, R.C., Wakil, S.M., Kazim, S.N., Kaul, R., Agarwal, S.R., Raisuddin, S., Hasnain, S.E. & Sarin, S.K. (2000) Beneficial effects of lamivudine in hepatitis B virus-related decompensated cirrhosis. J. Hepatol., 33, 308-312.
6. Kikuchi, K., Niitsuma, H., Ishii, M., Julieta, G. C., Shang, H., Ojima, T., Suzuki, C., Kobayashi, T., Ueno, Y., Kobayashi, K., Shimosegawa, T. & Toyota, T (2000) Genoepidemiology and its relationship to clinical features in patients infected chronically with hepatitis B virus (HBV). Hepatol. Res., 17,43-55.
7. Lee, W.M. (1997) Hepatitis B virus infection. N. Engl. J. Med., 337, 1733-1745.
8. Leung, N.W., Lai, C.L., Chang, T.T., Guan, R., Lee, C.M., Ng, K.Y., Lim, S.G., Wu, P.C., Dent, J.C., Edmundson, S., Condreay, L.D. & Chien, R.N. (2001) Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapy. Hepatology, 33, 1527-1532.
9. Liaw, Y.F., Leung, N.W., Chang, T.T., Guan, R., Tai, D.I., Ng, K.Y., Chien, R.N., Dent, J., Roman, L., Edmundson, S. & Lai, C.L. (2000) Effects of extended lamivudine therapy in asian patients with chronic hepatitis B. Asia hepatitis lamivudine study group. Gastroenterology, 119, 172-180.
10. Maddrey, W.C. (2000) Hepatitis B: An important public health issue. J. Med. Virol., 61, 362-366.
11. Nagasaki, F., Ueno, Y., Mano, Y., Igarashi, T., Yahagi, K., Niitsuma, H., Okamoto, H. & Shimosegawa, T. (2005) A patient with clinical features of acute hepatitis E viral infection and autoimmune hepatitis. Tohoku J. Exp. Med., 206, 173-179.
12. Norder, H., Hammas, B., Lofdahl, S., Courouce, A.M. & Magnius, L.O. (1992) Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains. J. Gen. Virol., 73, 1201-1208.
13. Okamoto, H., Imai, M., Tsuda, F., Tanaka, T, Miyakawa, Y. & Mayumi, M. (1987) Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr. J. Virol., 61, 3030-3034.
14. Okamoto, H., Tsuda, F., Sakugawa, H., Sastrosoewignjo, R.I., Imai, M., Miyakawa, Y. & Mayumi, M. (1988), Typing hepatitis B virus by homology in nucleotide sequence: Comparison of surface antigen subtypes. J. Gen. Virol., 69, 2575-2583.
15. Orito, E., Mizokami, M., Sakugawa, H., Michitaka, K., Ishikawa, K., Ichida, T., Okanoue, T., Yotsuyanagi, H. & Iino, S. (2001) A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV genotype research group. Hepatology, 33, 218-223.
16. Santantonio, T., Mazzola, M., Iacovazzi, T., Miglietta, A., Guastadisegni, A. & Pastore, G. (2000) Long-term follow-up of patients with anti-hbe/hbv DNA-positive chronic hepatitis B treated for 12 months with lamivudine. J. Hepatol, 32, 300-306.
17. Stuyver, L., De Gendt, S., Van Geyt, C., Zoulim, F., Fried, M., Schinazi, R.F. & Rossau, R. (2000) A new genotype of hepatitis B virus: Complete genome and phylogenetic relatedness. J. Gen. Virol., 81, 67-74.
18. Villeneuve, J.P., Condreay, L.D., Willems, B., Pomier-Layrargues, G., Fenyves, D., Bilodeau, M., Leduc R., Peltekian, K., Wong, F., Margulies, M. & Heathcote, E.J. (2000) Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B. Hepatology, 31, 207-210.
19. Yang, H.I., Lu, S.N., Liaw, Y.F., You, S.L., Sun, C.A., Wang, L.Y., Hsiao, C.K., Chen, P.J., Chen, D.S. & Chen, C.J. (2002) Hepatitis B e antigen and the risk of hepatocellular carcinoma. N. Engl. J. Med., 347, 168-174.
20. Yao, F.Y., Terrault, N.A., Freise, C., Maslow, L. & Bass, N.M. (2001) Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: A comparative study using a matched, untreated cohort. Hepatology, 34, 411-416.